Inventor · disambiguated record
Hyun O. Ok
Also filed as: OK HYUN · OK HYUN O
20 granted patents·6 pending applications·523 citations·filing 1990–2012
95Inventor score
Top patents by PatentIndex Score
26 records- 0196US5451677ASubstituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesityMERCK & CO INC·Filed 1993·Granted Sep 19, 1995·77 cites·18 claims
- 0292US5561142ASubstituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesityMERCK & CO INC·Filed 1995·Granted Oct 1, 1996·78 cites·18 claims
- 0391US7026316B2Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2002·Granted Apr 11, 2006·46 cites·23 claims
- 0491US5317017AN-biphenyl-3-amido substituted benzolactams stimulate growth hormone releaseMERCK & CO INC·Filed 1992·Granted May 31, 1994·51 cites·13 claims
- 0588US5705515ASubstituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesityMERCK & CO INC·Filed 1996·Granted Jan 6, 1998·86 cites·13 claims
- 0682US5208241AN-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activityMERCK & CO INC·Filed 1991·Granted May 4, 1993·63 cites·32 claims
- 0781US5208228AAminomacrolides and derivatives having immunosuppressive activityMERCK & CO INC·Filed 1991·Granted May 4, 1993·54 cites·27 claims
- 0876US5714506ASelective β3 agonists for the treatment of diabetes and obesityMERCK & CO INC·Filed 1996·Granted Feb 3, 1998·21 cites·17 claims
- 0974US5068323AThermally re-arranged FK-506 derivatives having immunosuppressant activityMERCK & CO INC·Filed 1990·Granted Nov 26, 1991·14 cites·15 claims
- 1073US8367679B2Biaryl carboxamidesMERCK SHARP & DOHME·Filed 2009·Granted Feb 5, 2013·2 cites·21 claims
- 1170US5545734AAryl and heteroaryl macrolides having immunosuppressive activityMERCK & CO INC·Filed 1994·Granted Aug 13, 1996·13 cites·9 claims
- 1268US7459475B2Substituted triazoles as sodium channel blockersMERCK & CO INC·Filed 2004·Granted Dec 2, 2008·4 cites·37 claims
- 1366US7265128B23-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2004·Granted Sep 4, 2007·4 cites·52 claims
- 1455US5550233AAryl, alkyl, alkenyl and alkynylmacrolides having immunosuppressive activityMERCK & CO INC·Filed 1994·Granted Aug 27, 1996·7 cites·13 claims
- 1550US8470819B2Benzimidazole and aza-benzimidazole carboxamidesCHU LIN·Filed 2009·Granted Jun 25, 2013·0 cites·19 claims
- 1650US8124628B2Diaryl substituted alkanesCHU LIN·Filed 2007·Granted Feb 28, 2012·0 cites·29 claims
- 1750US2009074890A1Substituted Triazoles as Sodium Channel BlockersPARK MIN K·Filed 2004·Application pending·0 cites
- 1849US5057608AImmunoregulants, immunosuppressants, process to make ring expanded macrolide related to FK-506/FK-520MERCK & CO INC·Filed 1990·Granted Oct 15, 1991·3 cites·8 claims
- 1948US2011003815A1Diphenyl substituted cycloalkanesMERCK & CO INC·Filed 2008·Application pending·0 cites
- 2044US8426413B2Diaryl substituted alkanesCHU LIN·Filed 2012·Granted Apr 23, 2013·0 cites·17 claims
- 2144US2010144715A1Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel BlockersHOYT SCOTT B·Filed 2008·Application pending·0 cites
- 2243US2009258885A1Diphenylmethane Derivatives as Inhibitors of Leukotriene BiosynthesisARMSTRONG HELEN M·Filed 2006·Application pending·0 cites
- 2343US2009197883A1Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of UseARMSTRONG HELEN M·Filed 2006·Application pending·0 cites
- 2441US2010190761A1Diphenyl substituted alkanesOGAWA ANTHONY·Filed 2008·Application pending·0 cites
- 2540US8440672B2Diphenyl substituted alkanesOGAWA ANTHONY·Filed 2007·Granted May 14, 2013·0 cites·24 claims
- 2639US9029377B2Platelet-activating factor receptor antagonistsOGAWA ANTHONY·Filed 2010·Granted May 12, 2015·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Hyun O. Ok files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →